Plasma Protein Systems Market
Plasma Protein Systems Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Plasma Protein Systems Market Size and Growth
The Plasma Protein Systems market is experiencing robust growth, driven by increasing demand for immunoglobulins and clotting factors. Current market size is estimated at approximately $25 billion, with a projected CAGR of 9% over the next five years, influenced by rising healthcare needs and advancements in therapeutic applications. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ CSL Plasma
◍ Grifols
◍ Biotest
◍ Kedrion
◍ Kamada
◍ Octapharma
◍ China Biologic Products Holdings
◍ Hualan Biological Engineering
The Plasma Protein Systems Market features key players like CSL Plasma, Grifols, and Octapharma, providing therapies for hemophilia and immune disorders. These companies drive growth through R&D, extensive distribution networks, and innovative products. Sales revenues include:
- CSL Plasma: ~$10 billion
- Grifols: ~$6.5 billion
- Octapharma: ~$3 billion.
Request Sample Report
Market Segmentation
By Application
◍ Hemophilia
◍ Primary Immunodeficiency Disorder
◍ Hereditary Angioedema
◍ Others
By Product
◍ Albumin
◍ Immunoglobulin
◍ Coagulation Factor
◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ 26.66 Billion
